Author

Kevin Xu

Observed institution: Jazz Pharmaceuticals (United States)

OpenAlex ID: A5079400364

0395 Effectiveness and Treatment Optimization Among Participants With Narcolepsy Switching From Sodium Oxybate to Lower-Sodium Oxybate: Interim Data From the SEGUE Study

2022 · Eileen Leary, Todd Kirby, et al. · SLEEP · 2

A double-blind, randomized, multicenter, phase 2b study of the safety and efficacy of suvecaltamide in essential tremor

2026 · Rajesh Pahwa, Rodger Elble, et al. · Parkinsonism & Related Disorders

Design of a Phase 2 Study of Suvecaltamide in Moderate-to-severe Parkinson’s Disease Tremor (P9-3.009)

2024 · Tara Skarpaas, Robert Hauser, et al. · Neurology

Effectiveness and Optimization of Low-Sodium Oxybate in Participants With Narcolepsy Switching From High-Sodium Oxybate: Interim Data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study (P5-13.003)

2023 · Eileen Leary, Todd Kirby, et al. · Neurology

Works count: 4

Citation count: 2

H-index: 1

I10-index: